secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2022-05-23T23:59:59+00:00
Accession:  0001193125-22-157503
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam stockholders re-elect three Class III directors at 2022 annual meeting
------------------------------------------------------------------------------

- Margaret A. Hamburg, Colleen F. Reitan, Amy W. Schulman re-elected as Class III directors.
- Stockholders approved amendment to 2018 Stock Incentive Plan with 93.4M for, 12.4M against.
- Non-binding advisory vote on executive compensation passed with 95.3M for, 10.5M against.
- PricewaterhouseCoopers ratified as independent auditor for FY 2022 with 109.7M for, 0.6M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312522157503/0001193125-22-157503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312522157503/d362069d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-157503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer